HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,543,728 | +75.5% | 47,108 | +88.5% | 0.00% | +50.0% |
| Q2 2023 | $879,538 | -27.0% | 24,994 | -32.3% | 0.00% | 0.0% |
| Q1 2023 | $1,204,946 | -81.7% | 36,905 | -69.2% | 0.00% | -85.7% |
| Q4 2022 | $6,593,428 | -18.3% | 119,663 | -34.4% | 0.01% | -22.2% |
| Q3 2022 | $8,069,000 | +136.7% | 182,334 | +161.0% | 0.02% | +157.1% |
| Q2 2022 | $3,409,000 | +456.1% | 69,860 | +456.4% | 0.01% | +600.0% |
| Q1 2022 | $613,000 | +76.1% | 12,556 | +53.3% | 0.00% | 0.0% |
| Q4 2021 | $348,000 | +55.4% | 8,193 | +39.5% | 0.00% | – |
| Q3 2021 | $224,000 | -45.9% | 5,872 | -52.2% | 0.00% | -100.0% |
| Q3 2020 | $414,000 | – | 12,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |